Human serum teratogenicity studied by rat embryo culture: epilepsy, anticonvulsant drugs, and nutrition. 1984

C L Chatot, and N W Klein, and M L Clapper, and S R Resor, and W D Singer, and B S Russman, and G L Holmes, and R H Mattson, and J A Cramer

Epileptic women have a greater risk for spontaneous abortions and children with birth defects than do nonepileptics. In a unique approach to identifying causes of these problems, we have cultured whole rat embryos for 48 h on blood sera from epileptics. In the first part of the study, three embryos were cultured on each serum sample from 128 different epileptics being treated with either single anticonvulsants or no drug to compare the teratogenicity of these drugs. Sera from subjects receiving either phenobarbital or no drug had comparable frequencies of cultured embryo abnormalities, which were lower than those from subjects taking phenytoin, valproic acid, or carbamazepine. In the second phase of the study, attempts to identify causes for serum teratogenicity led to the finding that the abnormalities and reduced embryo growth produced by many serum samples could be completely overcome by adding vitamins and/or amino acids to the serum. Of 53 samples tested, 32 (60%) were corrected by supplementation (17 of 23 phenytoin, seven of nine phenobarbital, six of 12 carbamazepine, none of six valproic acid, and two of three no drug). Although the results of this study provided a general assessment of drug teratogenicity that agreed with other studies and emphasized the role of nutrition in fetal defects, the importance of individual differences in causes of teratogenicity was also noted.

UI MeSH Term Description Entries
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004622 Embryo, Mammalian The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS. Embryonic Structures, Mammalian,Mammalian Embryo,Mammalian Embryo Structures,Mammalian Embryonic Structures,Embryo Structure, Mammalian,Embryo Structures, Mammalian,Embryonic Structure, Mammalian,Embryos, Mammalian,Mammalian Embryo Structure,Mammalian Embryonic Structure,Mammalian Embryos,Structure, Mammalian Embryo,Structure, Mammalian Embryonic,Structures, Mammalian Embryo,Structures, Mammalian Embryonic
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000013 Congenital Abnormalities Malformations of organs or body parts during development in utero. Birth Defects,Congenital Defects,Deformities,Fetal Anomalies,Fetal Malformations,Abnormalities, Congenital,Defects, Congenital,Abnormality, Congenital,Anomaly, Fetal,Birth Defect,Congenital Abnormality,Congenital Defect,Defect, Birth,Defect, Congenital,Deformity,Fetal Anomaly,Fetal Malformation,Malformation, Fetal
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D014815 Vitamins Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body. Vitamin

Related Publications

C L Chatot, and N W Klein, and M L Clapper, and S R Resor, and W D Singer, and B S Russman, and G L Holmes, and R H Mattson, and J A Cramer
January 1983, Research publications - Association for Research in Nervous and Mental Disease,
C L Chatot, and N W Klein, and M L Clapper, and S R Resor, and W D Singer, and B S Russman, and G L Holmes, and R H Mattson, and J A Cramer
November 1985, American journal of medical genetics,
C L Chatot, and N W Klein, and M L Clapper, and S R Resor, and W D Singer, and B S Russman, and G L Holmes, and R H Mattson, and J A Cramer
November 1984, American journal of medical genetics,
C L Chatot, and N W Klein, and M L Clapper, and S R Resor, and W D Singer, and B S Russman, and G L Holmes, and R H Mattson, and J A Cramer
April 2001, The New England journal of medicine,
C L Chatot, and N W Klein, and M L Clapper, and S R Resor, and W D Singer, and B S Russman, and G L Holmes, and R H Mattson, and J A Cramer
January 1991, Teratology,
C L Chatot, and N W Klein, and M L Clapper, and S R Resor, and W D Singer, and B S Russman, and G L Holmes, and R H Mattson, and J A Cramer
May 1980, Deutsche medizinische Wochenschrift (1946),
C L Chatot, and N W Klein, and M L Clapper, and S R Resor, and W D Singer, and B S Russman, and G L Holmes, and R H Mattson, and J A Cramer
July 1985, Federation proceedings,
C L Chatot, and N W Klein, and M L Clapper, and S R Resor, and W D Singer, and B S Russman, and G L Holmes, and R H Mattson, and J A Cramer
January 1992, Archives of toxicology,
C L Chatot, and N W Klein, and M L Clapper, and S R Resor, and W D Singer, and B S Russman, and G L Holmes, and R H Mattson, and J A Cramer
April 2002, Journal of medical genetics,
C L Chatot, and N W Klein, and M L Clapper, and S R Resor, and W D Singer, and B S Russman, and G L Holmes, and R H Mattson, and J A Cramer
November 1984, American journal of medical genetics,
Copied contents to your clipboard!